Design Therapeutics, Inc. (DSGN)
12.24
-0.57
(-4.45%)
USD |
NASDAQ |
Sep 18, 16:00
12.26
+0.02
(+0.16%)
After-Hours: 20:00
Design Therapeutics Price to Book Value : 3.795 for Sept. 18, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 3.795 |
| September 17, 2026 | 3.971 |
| September 16, 2026 | 3.877 |
| September 15, 2026 | 3.79 |
| September 14, 2026 | 4.192 |
| September 11, 2026 | 4.536 |
| September 10, 2026 | 4.588 |
| September 09, 2026 | 4.656 |
| September 08, 2026 | 4.722 |
| September 04, 2026 | 4.694 |
| September 03, 2026 | 4.660 |
| September 02, 2026 | 4.815 |
| September 01, 2026 | 4.694 |
| August 31, 2026 | 4.678 |
| August 28, 2026 | 4.684 |
| August 27, 2026 | 4.728 |
| August 26, 2026 | 4.833 |
| August 25, 2026 | 4.861 |
| August 24, 2026 | 4.722 |
| August 21, 2026 | 4.647 |
| August 20, 2026 | 4.824 |
| August 19, 2026 | 4.942 |
| August 18, 2026 | 4.734 |
| August 17, 2026 | 4.681 |
| August 14, 2026 | 4.598 |
| Date | Value |
|---|---|
| August 13, 2026 | 4.461 |
| August 12, 2026 | 4.545 |
| August 11, 2026 | 4.532 |
| August 10, 2026 | 4.443 |
| August 07, 2026 | 4.337 |
| August 06, 2026 | 4.269 |
| August 05, 2026 | 4.207 |
| August 04, 2026 | 4.092 |
| August 03, 2026 | 3.956 |
| July 31, 2026 | 3.776 |
| July 30, 2026 | 3.912 |
| July 29, 2026 | 3.726 |
| July 28, 2026 | 3.680 |
| July 27, 2026 | 3.683 |
| July 24, 2026 | 3.652 |
| July 23, 2026 | 3.606 |
| July 22, 2026 | 3.652 |
| July 21, 2026 | 3.739 |
| July 20, 2026 | 3.680 |
| July 17, 2026 | 3.897 |
| July 16, 2026 | 3.909 |
| July 15, 2026 | 4.192 |
| July 14, 2026 | 4.238 |
| July 13, 2026 | 4.295 |
| July 10, 2026 | 4.709 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| AnaptysBio, Inc. | 125.71 |
| 4D Molecular Therapeutics, Inc. | 2.061 |
| Inhibrx Biosciences, Inc. | -- |
| Agenus, Inc. | -- |
| Amgen, Inc. | 17.84 |
Price to Book Value Related Metrics
| PEG Ratio | -1.880 |
| Price | 12.24 |
| Earnings Yield | -9.64% |
| Market Cap | 765.98M |
| PEGY Ratio | -1.880 |